X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/23/2867503/0/en/Skye-Bioscience-to-Present-at-Upcoming-Investment-Conferences.html
https://endpts.com/skye-bioscience-lands-first-biopharma-uplisting-onto-nasdaq-since-last-summer/
https://www.globenewswire.com/news-release/2024/04/10/2860678/0/en/Skye-Bioscience-Uplists-to-The-Nasdaq-Global-Market.html
https://endpts.com/skye-bioscience-uplists-oncoxs-licensing-deal-with-abvc-biopharma/
https://www.globenewswire.com//news-release/2024/03/04/2839381/0/en/Skye-Bioscience-Appoints-Dr-Annalisa-Jenkins-to-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/02/26/2835005/0/en/Skye-Bioscience-Completes-Enrollment-of-Phase-2a-Clinical-Trial-of-SBI-100-Ophthalmic-Emulsion-in-Glaucoma-and-Ocular-Hypertension.html
https://www.globenewswire.com//news-release/2023/12/11/2793725/0/en/Skye-Announces-Clinical-Development-Plan-in-Obesity-for-Differentiated-Peripheral-CB1-Inhibitor-Nimacimab.html
https://www.globenewswire.com//news-release/2023/11/28/2786801/0/en/Skye-Bioscience-Treats-First-Patient-in-Glaucoma-Phase-2-Study-of-SBI-100-Ophthalmic-Emulsion.html
https://endpts.com/skye-acquires-bird-rock-bio-weeks-after-novo-nordisk-says-it-will-buy-a-cb1-developer/
https://www.clinicaltrialsarena.com/news/skye-enrolment-sbi-100/
Market Place
Share 
